General Information of Drug Off-Target (DOT) (ID: OTEWLMNB)

DOT Name Zinc finger protein DPF3 (DPF3)
Synonyms BRG1-associated factor 45C; BAF45C; Zinc finger protein cer-d4
Gene Name DPF3
Related Disease
Age-related macular degeneration ( )
Atrial fibrillation ( )
Breast cancer ( )
Breast carcinoma ( )
Male infertility ( )
Renal cell carcinoma ( )
Clear cell renal carcinoma ( )
Familial atrial fibrillation ( )
Hirschsprung disease ( )
Small lymphocytic lymphoma ( )
UniProt ID
DPF3_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
2KWJ; 2KWK; 2KWN; 2KWO; 5I3L; 5SZB; 5SZC
Pfam ID
PF14051 ; PF00628
Sequence
MATVIHNPLKALGDQFYKEAIEHCRSYNSRLCAERSVRLPFLDSQTGVAQNNCYIWMEKR
HRGPGLAPGQLYTYPARCWRKKRRLHPPEDPKLRLLEIKPEVELPLKKDGFTSESTTLEA
LLRGEGVEKKVDAREEESIQEIQRVLENDENVEEGNEEEDLEEDIPKRKNRTRGRARGSA
GGRRRHDAASQEDHDKPYVCDICGKRYKNRPGLSYHYAHTHLASEEGDEAQDQETRSPPN
HRNENHRPQKGPDGTVIPNNYCDFCLGGSNMNKKSGRPEELVSCADCGRSGHPTCLQFTL
NMTEAVKTYKWQCIECKSCILCGTSENDDQLLFCDDCDRGYHMYCLNPPVAEPPEGSWSC
HLCWELLKEKASAFGCQA
Function
Belongs to the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a post-mitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to post-mitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth. Muscle-specific component of the BAF complex, a multiprotein complex involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Specifically binds acetylated lysines on histone 3 and 4 (H3K14ac, H3K9ac, H4K5ac, H4K8ac, H4K12ac, H4K16ac). In the complex, it acts as a tissue-specific anchor between histone acetylations and methylations and chromatin remodeling. It thereby probably plays an essential role in heart and skeletal muscle development; [Isoform 2]: Acts as a regulator of myogenesis in cooperation with HDGFL2. Mediates the interaction of HDGFL2 with the BAF complex. HDGFL2-DPF3a activate myogenic genes by increasing chromatin accessibility through recruitment of SMARCA4/BRG1/BAF190A (ATPase subunit of the BAF complex) to myogenic gene promoters.
KEGG Pathway
ATP-dependent chromatin remodeling (hsa03082 )
Thermogenesis (hsa04714 )
Hepatocellular carcinoma (hsa05225 )

Molecular Interaction Atlas (MIA) of This DOT

10 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Age-related macular degeneration DIS0XS2C Strong Genetic Variation [1]
Atrial fibrillation DIS15W6U Strong Genetic Variation [2]
Breast cancer DIS7DPX1 Strong Biomarker [3]
Breast carcinoma DIS2UE88 Strong Biomarker [3]
Male infertility DISY3YZZ Strong Genetic Variation [4]
Renal cell carcinoma DISQZ2X8 Strong Genetic Variation [5]
Clear cell renal carcinoma DISBXRFJ moderate Genetic Variation [5]
Familial atrial fibrillation DISL4AGF moderate Biomarker [2]
Hirschsprung disease DISUUSM1 moderate Biomarker [6]
Small lymphocytic lymphoma DIS30POX moderate Biomarker [7]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
4 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Zinc finger protein DPF3 (DPF3). [8]
Tretinoin DM49DUI Approved Tretinoin increases the expression of Zinc finger protein DPF3 (DPF3). [9]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Zinc finger protein DPF3 (DPF3). [10]
Cisplatin DMRHGI9 Approved Cisplatin decreases the expression of Zinc finger protein DPF3 (DPF3). [11]
------------------------------------------------------------------------------------
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Zinc finger protein DPF3 (DPF3). [12]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the methylation of Zinc finger protein DPF3 (DPF3). [13]
------------------------------------------------------------------------------------

References

1 Genome-wide analysis of disease progression in age-related macular degeneration.Hum Mol Genet. 2018 Mar 1;27(5):929-940. doi: 10.1093/hmg/ddy002.
2 Multi-ethnic genome-wide association study for atrial fibrillation.Nat Genet. 2018 Jun 11;50(9):1225-1233. doi: 10.1038/s41588-018-0133-9.
3 Downregulation of DPF3 promotes the proliferation and motility of breast cancer cells through activating JAK2/STAT3 signaling.Biochem Biophys Res Commun. 2019 Jun 30;514(3):639-644. doi: 10.1016/j.bbrc.2019.04.170. Epub 2019 May 7.
4 Association of TUSC1 and DPF3 gene polymorphisms with male infertility.J Assist Reprod Genet. 2018 Feb;35(2):257-263. doi: 10.1007/s10815-017-1052-x. Epub 2017 Oct 3.
5 Sex specific associations in genome wide association analysis of renal cell carcinoma.Eur J Hum Genet. 2019 Oct;27(10):1589-1598. doi: 10.1038/s41431-019-0455-9. Epub 2019 Jun 23.
6 Expression profiles of HA117 and its neighboring gene DPF3 in different colon segments of Hirschsprung's disease.Int J Clin Exp Pathol. 2014 Jun 15;7(7):3966-74. eCollection 2014.
7 Identification of a STAT5 target gene, Dpf3, provides novel insights in chronic lymphocytic leukemia.PLoS One. 2013 Oct 14;8(10):e76155. doi: 10.1371/journal.pone.0076155. eCollection 2013.
8 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
9 Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol Sci. 2011 Dec;124(2):370-7.
10 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
11 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
12 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
13 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.